Authors


Thomas Swalla

Latest:

Don’t Get Distracted By AI, Instead Focus on Intellectual Property

Artificial intelligence is making it quicker to get drug candidates to the clinic, but it isn’t addressing the fundamental need to marry the right candidate and the right target to the right disease.


Bryan McSwiney, Brand Insights Contributor, Global Director of Technical Operations for Zenith Technologies, a Cognizant Company

Latest:

How Life Sciences Can Move to Manufacturing 4.0 While Meeting Market Demands

Here are four ways life sciences organizations can quickly and cost-effectively achieve Manufacturing 4.0 benefits while still getting treatments to market.


Jaime L.M. Jones

Latest:

In DOJ Crosshairs: Rethinking Commission-Based Deals With Independent Contractors

Pharma companies should review their commission-based compensation arrangements with independent contractors to address enforcement risk under the Anti-Kickback Statute, in light of recent Department of Justice enforcement.


Christa Toole

Latest:

What Do Pharma Marketers Need to Know About Voice?

Pharma marketers can use their "voice" to increase prominence in advertising.



Alex Simon

Latest:

Why Pharma Must Invest in Key Account Management Capabilities

The emergence of organized customers demands investment in advanced solutions and next-generation key account management.


T.J. Dmochowski

Latest:

Drug Manufacturers Take A Fresh Look as PAPs Continue to Hold Spotlight

Patient Assistance Programs (PAPs) came out of the shadows in 2020 as several factors aligned that increased demand and awareness of these programs.


Jenifer Slaw

Latest:

Silver Linings of a Global Health Crisis: A New Path Forward for Pharma Media Professionals

at some point, we won’t be seeing wall-to-wall COVID coverage anymore, but stories about the fallout. How can pharmaceutical brands prepare for what’s next?


Xavier Duburcq

Latest:

Tapping Compliance Data to Drive Success

How pharma leaders can convert data collected for compliance purposes from a cost center into a critical success factor.




RSM US

Latest:

The Secure Supply Chain in a DSCSA World

Webinar Date/Time: Wed, Nov 8, 2023 1:00 PM EST


Natalie Harb

Latest:

The Future of Launch Excellence is Generative AI

How drugmakers can reap value from using generative AI in their market-entry strategies and decision-making, including mitigating launch challenges and enhancing the customer conversation.


Xcenda

Latest:

Gaining Payer Attention Through Digital Innovation

In this case study, learn how to increase payer engagement, drive awareness, monitor competition, and leverage insights to enhance strategic plans and launch success.


Christoph Koenen

Latest:

Changing the Digital Health Playing Field: A New Era

The shift to clinical-grade support offers great opportunity.




Sam White

Latest:

To Tackle the Plastic Waste Crisis in Pharma, Here’s Where to Start

By demonstrating big advancements in recycling, pharma companies will be much more likely to attract shareholders and other investors, giving themselves a leg up in the competition to lead the biopharmaceutical industry well into the future.


Tom Knight

Latest:

Drug Diversion in Healthcare is a National Problem, but Recent Survey Shows a Promising Path Forward

Healthcare organizations can lower their risk of drug diversion by strengthening staffing, employee training, and technology.


Kim Schroer

Latest:

This is Your Wake-Up Call–Sunshine Act Enforcement is Here

Mitigating potential risk for stakeholders in light of latest Sunshine Act developments.


Alex Colborn

Latest:

Virtual’s Long-View Reality: Future Priorities and Perspectives

Telemedicine is definitely here to stay, but recent study may offer clues on its sustaining power.


Kristina Fusella

Latest:

Aspiring for the C-Suite? Consider Being a Chief of Staff

Why this role provides a critical ‘boot camp’ for future pharma leaders.


Jon Devries

Latest:

Beyond Images: 2024 Trends Reshaping Healthcare with Radiopharmaceuticals

By capitalizing on AI advancements, pushing the boundaries of personalized medicine with theranostics, and strengthening digital healthcare networks, radiopharmaceuticals are poised to transform healthcare from a reactive to a proactive discipline.


Sandor Schoichet

Latest:

Sustainability Sea Change: The Top 5 ESG Challenges for Pharma

Outlining the most important sustainability-related hurdles facing leading biopharma companies today—and current efforts underway to meet new expectations in advancing this strategic mandate.


Elizabeth Dignam

Latest:

Keys to Success for Social Media in Healthcare Advertising

How to build a loyal audience of brand evangelists.


Christine Nelson

Latest:

Teamwork for Better Healthcare Solutions: Merging Clinical and Marketing Efforts

In the ever-evolving landscape of healthcare, it's vital for organizations to take steps toward bridging the gap between their clinical and marketing teams.


Anne Elise Herold Li

Latest:

CRISPR: Maximizing this Revolutionary Genetic Tool While Minimizing IP Risk

New technology serves as reminder for the appropriate uses of CRISPR.



MERIT

Latest:

The Importance of Imaging and Centralized Review in Clinical Trials

Imaging is an integral part of many clinical studies, particularly in the fields of oncology and ophthalmology. Learn why imaging and centralized review are essential for clinical trials, how to address challenges that arise in these studies, and the advantages of partnering with MERIT in this video.


Simon Bates

Latest:

Building Healthcare Consumers’ Trust in Personalized Digital and Data-Led Services

The next few years will require life science companies to bring consumer-facing digital services to the core of their corporate competence, rather than leaving it at the periphery of their business capabilities.